Ahead of our virtual panel discussion on the promises and pitfalls of precision medicine trials: now and in the future […]
This is a summary of an article written by Alice Godden originally published on TheConversation. Of the nearly 3 billion […]
Last week, we wrote a blog post on the benefits of integrating genomics into clinical trials, such as improved methods […]
Genomics has the potential to improve efficacy of drugs and accelerate precision healthcare, but one area with the biggest potential […]
“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]
Cancer Research UK (CRUK) has funded a project run by a team of researchers at the University of Bristol to […]
The catalogue, Human Vaginal Non-Redundant gene catalogue (VIRGO), has been released publicly and can be used to facilitate an in-depth understanding of how the vaginal micro-organisms affect women’s health
We know from twin studies that Schizophrenia carries a 80% heritability risk, but haven’t yet managed to deduce exact genetic […]
FLG: Can you introduce yourself and your work? I’m Sandra Smieszek and I’m the Head of Genetics at Vanda Pharmaceuticals […]
Rory Collins, Principal Investigator and Chief Executive of UK Biobank leads this landmark project. We talk to him about some of the research outcomes from UK Biobank, and why he’s excited to be speaking at the Festival of Genomics this January.
